Related Experiment Video
Updated: May 27, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Hazard analysis and risk assessment in the development of biomedical drug formulation equipment
David H Johnson1, Martha W Bidez, Lawrence J Delucas
1Department of Biomedical Engineering, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA. dhj@uab.edu
Abstract:
Hazard analysis and risk assessment techniques are utilized within many private sector industries and government agencies, including the medical device and pharmaceutical industry, within a structured process to control human injuries and environmental and property damage. In the U.S. the Federal Drug Administration (FDA) requires a hazard analysis be performed on all medical devices. While there are biomedical engineering applications reported which deal with human hazards in clinical, patient care environment, no previous studies extend these traditional techniques to a university-based, research environment. This study applies a tiered approach to hazard analysis and risk assessment to a biomedical, university-based, research environment in the design of a high throughput platform that screens chemical excipients (additives) for their ability to increase protein solubility. Each design stage (conceptual, preliminary, system, and detailed) requires a unique hazard analysis technique based on available information. The analysis techniques applied here are evaluated for their use in a biomedical research environment where experiment accuracy is a primary concern.
More Related Videos
Related Concept Videos
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Analysis and Critical Control Points (HACCP)
Hazard Rate
Pharmaceutical Poisoning: Potential Scenarios
Preclinical Development: Overview

